These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Treatment and prevention of stomach and duodenal ulcers]. Diener HC Med Monatsschr Pharm; 1998 Oct; 21(10):314. PubMed ID: 9800465 [No Abstract] [Full Text] [Related]
44. Present and future treatment of peptic ulcer and potential role of DE-NOL. Scand J Gastroenterol Suppl; 1982; 80():49-57. PubMed ID: 6761852 [No Abstract] [Full Text] [Related]
45. Ulcer management: new drugs, new questions. Lorber SH Clin Ther; 1985; 8(1):2-4. PubMed ID: 3833370 [No Abstract] [Full Text] [Related]
46. A comparison of 4-week peptic ulcer healing rates following treatment with antacids and ranitidine. Bezuidenhout DJ; Perold JG; Adams G S Afr Med J; 1984 Jun; 65(25):1007-9. PubMed ID: 6328685 [TBL] [Abstract][Full Text] [Related]
48. Comparison of sucralfate and cimetidine in the treatment of duodenal and gastric ulcers. A multicenter study. Pop P; Nikkels RE; Thys O; Dorrestein GC Scand J Gastroenterol Suppl; 1983; 83():43-7. PubMed ID: 6356320 [TBL] [Abstract][Full Text] [Related]
49. [The medical therapy of peptic ulcer. The state of the art]. Perroni GB; De Matteis G; Pellizzeri F; Cassone A; Malara F Minerva Chir; 1992 Apr; 47(7):607-12. PubMed ID: 1350332 [No Abstract] [Full Text] [Related]
50. Recurrent ulcer treated with colloidal bismuth. Koo J; Lam SK Med J Aust; 1983 Feb; 1(3):103-4. PubMed ID: 6571529 [No Abstract] [Full Text] [Related]
51. [The validation and effect of the prophylactic (antirelapse) treatment of peptic ulcer patients with chlorozil and metronidazole]. Tsimmerman IaS; Kiseleva RP; Freĭnd GG Klin Med (Mosk); 1996; 74(2):58-60. PubMed ID: 8772110 [No Abstract] [Full Text] [Related]
53. The effect of lansoprazole treatment on the healing and relapse of peptic ulcer and serum levels of IgG anti-Helicobacter pylori antibody. Mine T; Yasuda H; Akimoto K; Katoaka A; Mashima H; Tajima A; Fukujin H; Tsuchida T; Takano T; Nagasawa J J Clin Gastroenterol; 1995; 20 Suppl 2():S75-8. PubMed ID: 7594347 [TBL] [Abstract][Full Text] [Related]
54. A review of the therapeutic efficacy of misoprostol, a prostaglandin E1 analogue. Nicholson PA S Afr Med J; 1988 Jul; 74 Suppl():56-8. PubMed ID: 3133797 [No Abstract] [Full Text] [Related]
55. [Serum thyrotropin and thyroxine in patients with peptic ulcer]. Selivonenko VG Klin Med (Mosk); 1983 Apr; 61(4):64-5. PubMed ID: 6865292 [No Abstract] [Full Text] [Related]
56. [A comparative evaluation of the efficacy of the monotherapy of peptic ulcer using EHF-puncture and basic drug therapy]. Razumov AN; Voznesenskaia OA Vopr Kurortol Fizioter Lech Fiz Kult; 1999; (5):10-1. PubMed ID: 10598520 [TBL] [Abstract][Full Text] [Related]
57. [Current directions in the treatment of gastric and duodenal ulcers]. Fellus R Dakar Med; 1988; 33(1-4):42-4. PubMed ID: 2908566 [No Abstract] [Full Text] [Related]
58. [Non-alternative elements in the pathogenesis of peptic ulcer and their modulation with sodium nucleinate]. Perederiĭ VG; Zemskov AM Ter Arkh; 1983; 55(2):29-32. PubMed ID: 6189204 [No Abstract] [Full Text] [Related]
59. [Losek (omeprazole), a new therapeutic agent in the treatment of peptic ulcer and hyperacidity states]. Bulgakov SA Klin Med (Mosk); 1995; 73(5):11-6. PubMed ID: 8815266 [No Abstract] [Full Text] [Related]
60. [Recent studies on therapy of peptic ulcers]. Asaka M Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1750-4. PubMed ID: 10581758 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]